Valuation : ALTEOGEN Inc.

Market Cap 19,462B 14.52B 12.5B 11.77B 10.72B 20.06B 1,382B 20.14B 139B 53.9B 704B 54.53B 53.35B 2,230B P/E 2026 *
65.5x
P/E 2027 * 48.3x
Enterprise Value 18.98B 14.17M 12.19M 11.48M 10.46M 19.57M 1.35B 19.65M 136M 52.58M 687M 53.19M 52.04M 2.18B EV / Sales 2026 *
40.4x
EV / Sales 2027 * 28.4x
Free-Float
74.26%
Yield 2026 *
0.17%
Yield 2027 * 0.2%
1 day+0.90%
1 week-7.14%
Current month-9.11%
1 month-8.36%
3 months+25.51%
6 months-2.59%
Current year-19.17%
1 week 268,500
Extreme 268500
313,500
1 month 268,500
Extreme 268500
356,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 33,846.15
Extreme 33846.153846
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap. Importance
5/21/25 Exercice

Chief Executive Officer

7,200 0.0135%
3/27/24 Sell 1,600,000 3.0182%
1/5/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%-7.14%-23.99%+726.73% 14.38B
-0.33%-1.96%+44.63%-2.77% 80.91B
-2.05%-0.64%-19.76%-36.79% 60.46B
-3.36%-12.10%+446.15%+25.98% 56.02B
+0.83%-4.47%-8.40%+30.44% 49.63B
-1.11%-6.36%-2.76%+147.94% 45.88B
-0.83%-2.46%+49.08%-18.63% 31.4B
+1.29%+0.80%+45.58%+96.95% 25.22B
-2.00%-3.35%-2.29%+177.79% 22.25B
-3.02%-3.10%+60.58%+104.24% 16.59B
Average -0.44%-1.28%+58.88%+125.19% 40.27B
Weighted average by Cap. -0.32%-1.14%+74.91%+62.81%

Financials

2026 *2027 *
Net sales 470B 351M 302M 284M 259M 484M 33.37B 486M 3.37B 1.3B 17B 1.32B 1.29B 53.86B 660B 493M 424M 399M 364M 681M 46.89B 683M 4.73B 1.83B 23.89B 1.85B 1.81B 75.67B
Net income 298B 223M 192M 180M 164M 308M 21.19B 309M 2.14B 827M 10.8B 836M 818M 34.21B 379B 283M 243M 229M 209M 391M 26.91B 392M 2.72B 1.05B 13.71B 1.06B 1.04B 43.44B
Net Debt -478B -357M -307M -289M -263M -493M -33.94B -495M -3.43B -1.32B -17.29B -1.34B -1.31B -54.78B -730B -544M -469M -441M -402M -752M -51.81B -755M -5.23B -2.02B -26.39B -2.04B -2B -83.62B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
26-09-09 ₩279,500.00 +0.90% 544,699
26-09-08 ₩277,000.00 -3.15% 657,576
26-09-07 ₩286,000.00 -0.87% 481,793
26-09-04 ₩288,500.00 +1.94% 613,855
26-09-03 ₩283,000.00 -5.19% 1,248,714
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
279,500.00KRW
Average target price
382,051.28KRW
Spread / Average Target
+36.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!